{"success":true,"data":{"pressRelease":{"id":"30317","rtpr_id":"nBwLLf6da","ticker":"ANRO","exchange":"NYSE","all_tickers":["ANRO"],"title":"Alto Neuroscience Announces Participation in Upcoming Investor Conferences","author":"Business Wire","published_at":"2026-05-11T20:05:00.733Z","article_body":"Alto Neuroscience Announces Participation in Upcoming Investor Conferences\n\nAlto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage\nbiopharmaceutical company focused on the development of novel precision\nmedicines for neuropsychiatric disorders, today announced that members of the\nCompany’s management team will participate in the following upcoming\ninvestor conferences:\n\n\n * Bank of America Securities Healthcare Conference, May 12-14, 2026\n\n\n* Format: Company presentation and one-on-one meetings\n\n * Presentation Date & Time: May 13, 2026, 5:15 pm PDT\n\n * Location: Las Vegas, NV\n\n\n\n\n\n * Jefferies Global Healthcare Conference, June 2-4, 2026\n\n\n* Format: Fireside chat and one-on-one investor meetings\n\n * Presentation Date & Time: June 3, 2026, 9:20 am EDT\n\n * Location: New York, NY\n\n\n\n\nAvailable presentations will be accessible via a live webcast on the Events\nand Presentations\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Finvestors.altoneuroscience.com%2Fevents-and-presentations%2Fdefault.aspx&esheet=54533673&newsitemid=20260511292648&lan=en-US&anchor=Events+and+Presentations&index=1&md5=5c3db0f1b1a32d0d4c8edc079a98590d)\npage in the Investors section of Alto’s website and a replay will be\navailable following the presentation.\n\nAbout Alto Neuroscience\n\nAlto Neuroscience is a clinical-stage biopharmaceutical company with a mission\nto redefine psychiatry by leveraging neurobiology to develop personalized and\nhighly effective treatment options. Alto’s Precision Psychiatry Platform™\nmeasures brain biomarkers by analyzing EEG activity, neurocognitive\nassessments, wearable data, and other factors to better identify which\npatients are more likely to respond to Alto product candidates. Alto’s\nclinical-stage pipeline includes novel drug candidates in depression,\nschizophrenia, and other mental health conditions. For more information, visit\nwww.altoneuroscience.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.altoneuroscience.com%2F&esheet=54533673&newsitemid=20260511292648&lan=en-US&anchor=www.altoneuroscience.com&index=2&md5=37ab145f4456269cd5ee0c7e2cb6dab4)\nor follow Alto on X.\n\nAvailability of Information on Alto’s Website\n\nAlto routinely uses its investor relations website to post presentations to\ninvestors and other important information, including information that may be\nmaterial. Accordingly, Alto encourages investors and others interested in Alto\nto review the information it makes public on its investor relations website.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260511292648/en/\n(https://www.businesswire.com/news/home/20260511292648/en/)\n\nInvestor and Media Contact: \n\nNick Smith\n\ninvestors@altoneuroscience.com \n(mailto:investors@altoneuroscience.com) \nmedia@altoneuroscience.com (mailto:media@altoneuroscience.com)\n\n\nCopyright Business Wire 2026","article_body_html":"","raw_payload":{"data":{"id":"nBwLLf6da","title":"Alto Neuroscience Announces Participation in Upcoming Investor Conferences","author":"Business Wire","ticker":"ANRO","created":"2026-05-11T20:05:00.733Z","tickers":["ANRO"],"exchange":"NYSE","article_body":"Alto Neuroscience Announces Participation in Upcoming Investor Conferences\n\nAlto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage\nbiopharmaceutical company focused on the development of novel precision\nmedicines for neuropsychiatric disorders, today announced that members of the\nCompany’s management team will participate in the following upcoming\ninvestor conferences:\n\n\n * Bank of America Securities Healthcare Conference, May 12-14, 2026\n\n\n* Format: Company presentation and one-on-one meetings\n\n * Presentation Date & Time: May 13, 2026, 5:15 pm PDT\n\n * Location: Las Vegas, NV\n\n\n\n\n\n * Jefferies Global Healthcare Conference, June 2-4, 2026\n\n\n* Format: Fireside chat and one-on-one investor meetings\n\n * Presentation Date & Time: June 3, 2026, 9:20 am EDT\n\n * Location: New York, NY\n\n\n\n\nAvailable presentations will be accessible via a live webcast on the Events\nand Presentations\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Finvestors.altoneuroscience.com%2Fevents-and-presentations%2Fdefault.aspx&esheet=54533673&newsitemid=20260511292648&lan=en-US&anchor=Events+and+Presentations&index=1&md5=5c3db0f1b1a32d0d4c8edc079a98590d)\npage in the Investors section of Alto’s website and a replay will be\navailable following the presentation.\n\nAbout Alto Neuroscience\n\nAlto Neuroscience is a clinical-stage biopharmaceutical company with a mission\nto redefine psychiatry by leveraging neurobiology to develop personalized and\nhighly effective treatment options. Alto’s Precision Psychiatry Platform™\nmeasures brain biomarkers by analyzing EEG activity, neurocognitive\nassessments, wearable data, and other factors to better identify which\npatients are more likely to respond to Alto product candidates. Alto’s\nclinical-stage pipeline includes novel drug candidates in depression,\nschizophrenia, and other mental health conditions. For more information, visit\nwww.altoneuroscience.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.altoneuroscience.com%2F&esheet=54533673&newsitemid=20260511292648&lan=en-US&anchor=www.altoneuroscience.com&index=2&md5=37ab145f4456269cd5ee0c7e2cb6dab4)\nor follow Alto on X.\n\nAvailability of Information on Alto’s Website\n\nAlto routinely uses its investor relations website to post presentations to\ninvestors and other important information, including information that may be\nmaterial. Accordingly, Alto encourages investors and others interested in Alto\nto review the information it makes public on its investor relations website.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260511292648/en/\n(https://www.businesswire.com/news/home/20260511292648/en/)\n\nInvestor and Media Contact: \n\nNick Smith\n\ninvestors@altoneuroscience.com \n(mailto:investors@altoneuroscience.com) \nmedia@altoneuroscience.com (mailto:media@altoneuroscience.com)\n\n\nCopyright Business Wire 2026"},"type":"article","timestamp":"2026-05-11T20:05:01.622649455Z","server_sent_at_ms":1778529901622},"received_at":"2026-05-11T20:05:01.879Z","source_url":"https://www.businesswire.com/news/home/20260511292648/en/"},"analysis":{"id":"22454","press_release_id":"30317","analysis_json":{"industry":{"label":"Biotechnology","sector":"Health Care"},"redFlags":[],"eventType":"operations_update","narrative":"Alto Neuroscience will participate in the Bank of America Securities Healthcare Conference from May 12-14, 2026, with a company presentation and one-on-one meetings on May 13, 2026, at 5:15 pm PDT in Las Vegas, NV.\n\nThe company will also attend the Jefferies Global Healthcare Conference from June 2-4, 2026, featuring a fireside chat and one-on-one investor meetings on June 3, 2026, at 9:20 am EDT in New York, NY.\n\nPresentations will be accessible via a live webcast on the company's investor relations website, with replays available after the events.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine conference participation -- no material news."},"keyFigures":null,"quotedText":"","namedEntities":{"people":[{"name":"Nick Smith","role":"Investor and Media Contact"}],"products":[],"companies":[{"name":"Alto Neuroscience, Inc.","ticker":"ANRO","relationship":"filer"},{"name":"Bank of America Securities","relationship":"conference organizer"},{"name":"Jefferies Global Healthcare Conference","relationship":"conference organizer"}],"dollarAmounts":[]},"materialImpact":{"score":2,"reasoning":"Participation in investor conferences is routine and does not directly impact the company's financial performance or strategic direction."},"tickerRelevance":{"others":[],"primary":"ANRO"},"globalImportance":20,"audienceRelevance":30,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"routine conference participation","issuerAuthored":true}},"event_type":"operations_update","event_type_secondary":null,"sentiment":"neutral","material_impact_score":2,"narrative":"Alto Neuroscience will participate in the Bank of America Securities Healthcare Conference from May 12-14, 2026, with a company presentation and one-on-one meetings on May 13, 2026, at 5:15 pm PDT in Las Vegas, NV.\n\nThe company will also attend the Jefferies Global Healthcare Conference from June 2-4, 2026, featuring a fireside chat and one-on-one investor meetings on June 3, 2026, at 9:20 am EDT in New York, NY.\n\nPresentations will be accessible via a live webcast on the company's investor relations website, with replays available after the events.","key_figures":null,"named_entities":{"people":[{"name":"Nick Smith","role":"Investor and Media Contact"}],"products":[],"companies":[{"name":"Alto Neuroscience, Inc.","ticker":"ANRO","relationship":"filer"},{"name":"Bank of America Securities","relationship":"conference organizer"},{"name":"Jefferies Global Healthcare Conference","relationship":"conference organizer"}],"dollarAmounts":[]},"model_name":"Qwen/Qwen2.5-72B-Instruct-AWQ","prompt_hash":"sha256:a76fb3b19e8e8b7b","schema_hash":"sha256:8658c370b800cf3d","created_at":"2026-05-11T21:12:59.746Z","global_importance":20,"audience_relevance":30,"importance_components":{"tickerTier":"small-cap","eventGravity":"routine conference participation","issuerAuthored":true}},"durationMs":97794,"modelName":"george-droid-qwen-72b"}}